[Federal Register Volume 66, Number 115 (Thursday, June 14, 2001)]
[Notices]
[Page 32365]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-14961]



[[Page 32365]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Heart, Lung, and Blood Institute; Notice of Closed 
Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and/or contract proposals 
and the discussions could disclose confidential trade secrets or 
commercial property such as patentable material, and personal 
information concerning individuals associated with the grant 
applications and/or contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Heart, Lung, and Blood Institute 
Special Emphasis Panel Genetic Modifiers of Single Gene Defect 
Diseases.
    Date: June 25-26, 2001.
    Time: 7 p.m. to 5 p.m.
    Agenda: To review and evaluate grant applications and/or 
proposals.
    Place: Holiday Inn, 5520 Wisconsin Avenue, Chevy Chase, MD 
20815.
    Contact Person: Robert B. Moore, Scientific Review 
Administrator, Review Branch, Room 7192, Division of Extramural 
Affairs, National Heart, Lung, and Blood Institute, National 
Institutes of Health, Bethesda, MD 20892, 301-435-3541, 
[email protected].
    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

(Catalogue of Federal Domestic Assistance Program Nos. 93.233, 
National Center for Sleep Disorders Research; 93.837, Heart and 
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, 
Blood Diseases and Resources Research, National Institutes of 
Health, HHS)


    Dated: June 6, 2001.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 01-14961 Filed 6-13-01; 8:45 am]
BILLING CODE 4140-01-M